Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.

Eissa S, Shehata H, Mansour A, Esmat M, El-Ahmady O.

Med Oncol. 2012 Dec;29(5):3345-51. doi: 10.1007/s12032-012-0295-8. Epub 2012 Jul 4.

PMID:
22760792
2.

Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.

Eissa S, Swellam M, El-Khouly IM, Kassim SK, Shehata H, Mansour A, Esmat M, Nossier AI, Hamdy MA, Awad NM, El-Ahmady O.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1657-64. doi: 10.1158/1055-9965.EPI-11-0237. Epub 2011 Jun 15.

3.

Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.

Eissa S, Swellam M, Shehata H, El-Khouly IM, El-Zayat T, El-Ahmady O.

J Urol. 2010 Feb;183(2):493-8. doi: 10.1016/j.juro.2009.10.024. Epub 2009 Dec 14.

PMID:
20006858
4.

Bioequivalence of two oral formulations of clopidogrel tablets in healthy male volunteers.

El Ahmady O, Ibrahim M, Hussein AM, Bustami RT.

Int J Clin Pharmacol Ther. 2009 Dec;47(12):780-4.

PMID:
19954717
5.

A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.

Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O.

J Urol. 2009 Mar;181(3):1353-60. doi: 10.1016/j.juro.2008.10.102. Epub 2009 Jan 29.

PMID:
19185322
6.

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

Eissa S, Kassim SK, Labib RA, El-Khouly IM, Ghaffer TM, Sadek M, Razek OA, El-Ahmady O.

Cancer. 2005 Apr 1;103(7):1356-62.

7.

HER2/neu expression in bladder cancer: relationship to cell cycle kinetics.

Eissa S, Ali HS, Al Tonsi AH, Zaglol A, El Ahmady O.

Clin Biochem. 2005 Feb;38(2):142-8.

PMID:
15642276
8.

Cell cycle regulators in bladder cancer: relationship to schistosomiasis.

Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.

IUBMB Life. 2004 Sep;56(9):557-64.

9.

Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma.

Eissa S, Kenawy G, Swellam M, El-Fadle AA, Abd El-Aal AA, El-Ahmady O.

Clin Biochem. 2004 Sep;37(9):803-10.

PMID:
15329320
10.

Diagnostic value of urinary molecular markers in bladder cancer.

Eissa S, Swellam M, el-Mosallamy H, Mourad MS, Hamdy N, Kamel K, Zaglol AS, Khafagy MM, el-Ahmady O.

Anticancer Res. 2003 Sep-Oct;23(5b):4347-55.

PMID:
14666650
11.
12.

Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers.

Eissa S, Kassim S, El-Ahmady O.

Curr Opin Obstet Gynecol. 2003 Oct;15(5):395-403. Review.

PMID:
14501243
13.

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.

el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.

Anticancer Res. 2002 Jul-Aug;22(4):2493-9.

PMID:
12174951
14.
15.

The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.

el-Ahmady O, Halim AB, el-Din AG.

Anticancer Res. 1999 Jul-Aug;19(4A):2603-8.

PMID:
10470202
16.

Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage.

Halim AB, el-Ahmady O, Hassab-Allah S, Abdel-Galil F, Hafez Y, Darwish A.

Ann Clin Biochem. 1997 Nov;34 ( Pt 6):656-63.

PMID:
9367004
17.

The priming effects of some human interleukins on the production of leukotrienes by calcium ionophore stimulated leukocytes.

Mansour M, El-Ahmady O, Motawi T.

Biochem Mol Biol Int. 1997 Jul;42(4):817-24. doi: 10.1080/15216549700203251.

PMID:
19856299
18.
19.

Epidermal growth factor receptors: status and effect on breast cancer patients.

Mansour OA, Zekri AR, Harvey J, el-Ahmady O.

Anticancer Res. 1997 Jul-Aug;17(4B):3107-10.

PMID:
9329612
20.

Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.

Mansour OA, Zekri AR, Harvey J, Teramoto Y, el-Ahmady O.

Anticancer Res. 1997 Jul-Aug;17(4B):3101-6.

PMID:
9329611
21.

The clinical value of cathepsin-D and TNF-alpha in bladder cancer patients.

Salman T, el-Ahmady O, el-Shafee M, Omar S, Salman I.

Anticancer Res. 1997 Jul-Aug;17(4B):3087-90.

PMID:
9329608
22.

Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients.

Salman T, el-Ahmady O, Tony O, Darwish M.

Anticancer Res. 1997 Jul-Aug;17(4B):3083-6.

PMID:
9329607
23.

Sonolysis promotes indirect Co-C bond cleavage of alkylcob(III)alamin bioconjugates.

Howard WA Jr, Bayomi A, Natarajan E, Aziza MA, el-Ahmady O, Grissom CB, West FG.

Bioconjug Chem. 1997 Jul-Aug;8(4):498-502.

PMID:
9258447
24.

Elevated concentrations of interleukins and leukotriene in response to Mycobacterium tuberculosis infection.

el-Ahmady O, Mansour M, Zoeir H, Mansour O.

Ann Clin Biochem. 1997 Mar;34 ( Pt 2):160-4.

PMID:
9133249
25.

Comparative study between sonography, pathology and UGP in women with perimenopausal bleeding.

el-Ahmady O, Gad M, el-Sheimy R, Halim AB, Eissa S, Hassan F, Walker R.

Anticancer Res. 1996 Jul-Aug;16(4B):2309-13.

PMID:
8694561
26.

UGP in urogenital disorders: Egyptian experience.

el-Ahmady O, Halim AB, Gad M, Walker R.

Anticancer Res. 1996 Jul-Aug;16(4B):2301-8.

PMID:
8694560
27.

Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease.

el-Ahmady O, Halim AB, Mansour O, Salman T, el-Din AG, Walker RP.

Br J Cancer. 1996 Jun;73(12):1486-90.

28.

Cathepsin-D and TNF-alpha in bladder cancer.

Salman T, el-Ahmady O, el-Shafee M, Omar S, Salman I.

Dis Markers. 1996 Mar;12(4):253-9.

PMID:
8718785
29.

Serum copper, zinc, and iron in patients with malignant and benign pulmonary diseases.

el-Ahmady O, el-Maraghy A, Ibrahim A, Ramzy S.

Nutrition. 1995 Sep-Oct;11(5 Suppl):498-501.

PMID:
8748208
30.

Urinary CA 19.9 as marker for bladder cancer.

Mansour OA, Shouman SA, Khafagy M, Basma H, Liebmann PM, Schauenstein K, el-Ahmady O.

Lancet. 1995 Aug 19;346(8973):512-3. No abstract available.

PMID:
7637514
31.

The clinical value of serum TPS in gynecological malignancies.

Salman T, el-Ahmady O, Sawsan MR, Nahed MH.

Int J Biol Markers. 1995 Apr-Jun;10(2):81-6.

PMID:
7561243
32.

Elevated plasma level of leukotrienes in bronchial asthma patients: a possible clinical relevance.

Mansour M, Farouk N, el Maragy A, Radwan I, el-Ahmady O.

Dis Markers. 1995 Mar;12(2):117-22.

PMID:
7614780
33.

Urinary beta-HCG in benign and malignant urinary tract diseases.

Halim AB, Barakat M, el-Zayat AM, Daw M, el-Ahmady O.

Dis Markers. 1995 Mar;12(2):109-15.

PMID:
7542189
34.

Incidence of hepatitis C virus in Egyptians.

el-Ahmady O, Halim AB, Mansour O, Salman T.

J Hepatol. 1994 Oct;21(4):687. No abstract available.

PMID:
7814820
35.

Effect of sodium salicylate on insulin rectal absorption in humans.

Hosny E, el-Ahmady O, el-Shattawy H, Nabih A el-M, el-Damacy H, Gamal-el-Deen S, el-Kabbany N.

Arzneimittelforschung. 1994 May;44(5):611-3.

PMID:
8024632
36.

Clinical value of thymidine kinase and tissue polypeptide specific antigen in breast cancer.

Mansour O, Motawi T, Khaled H, el-Ahmady O.

Dis Markers. 1993 Nov;11(4):171-7.

PMID:
8112021
37.

Serum TPS versus TPA in Egyptian bladder cancer patients.

Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.

Int J Biol Markers. 1993 Oct-Dec;8(4):221-6.

PMID:
7511149
38.
39.

Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients.

Halim AB, el-Ahmady O, Hamza S, Aboul-Ela M, Oehr P.

Int J Biol Markers. 1992 Oct-Dec;7(4):234-9.

PMID:
1491179
40.

Plasma lipoprotein pattern and liver function tests versus histological picture in rats with experimental biliary obstruction.

Hamza S, el-Ahmady O, Halim A, Mahmoud E, Labib OH, Morsy TA.

J Egypt Soc Parasitol. 1987 Dec;17(2):777-83. No abstract available.

PMID:
3693969
41.

Pituitary and ovarian activities in human adult females with bilharzial hepatic fibrosis.

Zaki K, Hefnawi F, Hamza S, El-Ahmady O, Hamada F, Nour H.

Endokrinologie. 1982 Feb;79(1):57-64. No abstract available.

PMID:
6806083

Supplemental Content

Loading ...
Support Center